XML 39 R28.htm IDEA: XBRL DOCUMENT v3.25.3

REVENUE (Tables)

9 Months Ended

Sep. 30, 2025

Revenue from Contract with Customer [Abstract]

Schedule of disaggregation of revenue

The following table presents the Company’s revenues disaggregated by revenue source:

						Three Months Ended September 30,												Nine Months Ended September 30,
(In thousands)						2025						2024						2025						2024
Screening
Medicare Parts B & C						$	247,353					$	201,423					$	675,923					$	570,550
Commercial						354,867						289,637						978,565						827,509
Other						64,020						53,841						180,240						153,246
Total Screening						666,240						544,901						1,834,728						1,551,305
Precision Oncology
Medicare Parts B & C						$	50,924					$	47,080					$	144,732					$	142,597
Commercial						50,376						47,685						146,679						143,572
International						58,784						49,433						165,628						140,688
Other						24,415						19,556						76,842						67,281
Total Precision Oncology						184,499						163,754						533,881						494,138
Total						$	850,739					$	708,655					$	2,368,609					$	2,045,443

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-5

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration